Biaromatic ligand activators of PPARγ receptors

Details Biaromatic ligand activators of PPARγ receptors Biaromatic ligand activators of PPARγ receptors

2006-10-17

2006-10-17

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S438000, C514S461000, C514S507000, C546S329000, C549S083000, C549S505000, C560S019000

Reexamination Certificate

active

07122564

ABSTRACT:
Novel pharmaceutical/cosmetic compositions contain at least one biaromatic ligand activator of a PPARγ receptor, such biaromatic ligand having the structural formula (I):and are well suited, inter alia, for regulating and/or restoring skin lipid metabolism, for treating a wide variety of dermatological afflictions, and for preventing and/or treating the signs of aging and/or dry skin.

REFERENCES:
patent: 6908939 (2005-06-01), Bernardon et al.
patent: 1 067 109 (2001-01-01), None
patent: 2 812 876 (2002-02-01), None
patent: WO 01/14349 (2001-03-01), None
patent: WO 02/098840 (2002-12-01), None
Nomura et al., “(3-Substituted Benzyl)Thiazolidine-2,4-diones as Structurally New Antihyperglycemic Agents,” 9(4) Bioorganic & Medicinal Chemistry Letters, 533-538 (Feb. 22, 1999) Elsevier Science Ltd.
French Search Report, issued for FR 01/16750 on Aug. 16, 2002, 2 pages.
Ishihara et al., 2000, CAS:133:58799.

Affiliated with

Also associated with

Rating

Biaromatic ligand activators of PPARγ receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biaromatic ligand activators of PPARγ receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biaromatic ligand activators of PPARγ receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3718818